Computer Aided Auscultation of Phonopulmogram for Noninvasive Diagnosis of Interstitial Lung Diseases

Overview

About this study

The purpose of this study is to collect and annotate Phonopulmogram data from healthy volunteers, patients with Interstitial lung diseases, patients with occupational lung diseases or organic dust exposure, patients with autoimmune diseases, patients with post infectious lung fibrosis on Chest X-ray and patients with pulmonary toxicity associated with systemic antineoplastic therapy or radiation therapy for facilitating the technical development of the PPG based computer aided auscultation using Artificial Intelligence, and to develop and demonstrate the feasibility of a novel deep learning model that detects, distinguish between normal and pathological lung sounds and subclassifies adventitious lung sounds in patients with Interstitial lung diseases.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years old.
  • Healthy male and female volunteers OR meets one of the following criteria below:
    • Patients diagnosed with Interstitial pulmonary fibrosis;
    • Patients with occupational lung disease or organic dust exposure;
    • Patients with autoimmune lung disease;
    • Patients with post infectious lung fibrosis on Chest X-ray;
    • Patients with diagnosed pulmonary toxicity associated with systemic antineoplastic therapy or radiation therapy.

Exclusion Criteria: 

  • Inability or unwillingness to participate in study.
  • Age ≤ 17 years old.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/7/23. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Scott Helgeson, M.D.

Contact us for the latest status

Contact information:

Scott Helgeson M.D.

Helgeson.Scott@mayo.edu

More information

Publications

Publications are currently not available